Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial

J de Bruijn, H.J. Duivenvoorden, J. Passchier, H. Locher, N. Dijkstra, W.F. Arts

Research output: Contribution to JournalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial'. Together they form a unique fingerprint.

Medicine & Life Sciences